AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23735179
Drug: Vilanterol (VI)
RxNorm normalized name: Vilanterol
DrugBank: Vilanterol (DB09082)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vilanterol (VI) 50 μg
Trial: 22241764
Drug: Vilanterol (VI)
RxNorm normalized name: Vilanterol
DrugBank: Vilanterol (DB09082)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vilanterol (VI) 3, 6.25, 12.5, 25, or 50 μg
Trial: 9493699
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination of isradipine 2.5 mg plus spirapril 3 mg
Trial: 7687157
Drug: 10 mL
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL of 23% saturated hypertonic saline
Trial: 7687157
Drug: 30 mL
RxNorm normalized name: Vial M/T 30 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mL of 7.5% hypertonic saline
Trial: 7687157
Drug: 30 mL
RxNorm normalized name: Vial M/T 30 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mL of 7.5% saline with 6% dextran 70
Trial: 3599565
Drug: Amobarbital 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amobarbital 80 mg
Trial: 2660556
Drug: Sucralfate, 1
RxNorm normalized name: Sucralfate, 1 g oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate, 1 g twice daily
Trial: 27781419
Drug: Tablet form
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet form of mycophenolate mofetil
Trial: 27781419
Drug: Capsule form
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsule form of mycophenolate mofetil
Trial: 26200980
Drug: AVI-7288 (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AVI-7288 (1 mg, 4 mg, 8 mg, 12 mg, or 16 mg per kilogram of body weight)
Trial: 21661445
Drug: Domperidone (10mg)
RxNorm normalized name: Domperidone
DrugBank: Domperidone (DB01184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone (10mg) with 50 mL of water
Trial: 21661445
Drug: 50 mL
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mL of water alone
Trial: 15165089
Drug: Radiotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy plus cisplatin (20mg/m2 cisplatin 1 h before radiotherapy, given on days 1-5 of the second and sixth treatment weeks)
Trial: 3653081
Drug: Fentanyl (any
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (any dose)
Trial: 9217590
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg i.v. cocaine
Trial: 9217590
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg i.v. cocaine
Trial: 8353352
Drug: Celiac plexus
RxNorm normalized name: Bos taurus solar plexus preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celiac plexus block (30 mL of 0.25% bupivacaine)
Trial: 8353352
Drug: Placebo (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (30 mL of normal saline)
Trial: 3301504
Drug: Propafenone 450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone 450 mg or 900 mg daily
Trial: 27160639
Drug: Canagliflozin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Canagliflozin (100 mg and titrated to 300 mg)
Trial: 25612082
Drug: Skimmed milk,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skimmed milk, whey, casein (all milk-based drinks 35g protein/L)
Trial: 23786940
Drug: Benazepril 10
RxNorm normalized name: benazepril 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benazepril 10 mg/Lercanidipine 10 mg
Trial: 20442614
Drug: Massage intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage intervention (10 to 15 minutes daily starting at 15 days old)
Trial: 12797850
Drug: Modern medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modern medical therapies
Trial: 12797850
Drug: Conservative surgical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative surgical therapies
Trial: 8652316
Drug: Morphine (bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (bolus dose 2 mg, lockout time 10 min)
Trial: 8652316
Drug: Pethidine (bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pethidine (bolus dose 20 mg, lockout time 10 min)
Trial: 8652316
Drug: Morphine and
RxNorm normalized name: morphine and antispasmodics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine and Pethidine
Trial: 30802204
Drug: Ferumoxytol 1.02
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ferumoxytol 1.02 g (2 × 510 mg)
Trial: 30802204
Drug: Iron sucrose
RxNorm normalized name: Iron Sucrose
DrugBank: Iron sucrose (DB09146)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron sucrose 1.0 g (10 × 100 mg)
Trial: 12362928
Drug: Estradiol Transdermal
RxNorm normalized name: Estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estradiol Transdermal System (Mylan Pharmaceuticals, Inc.)
Trial: 10434162
Drug: Thiopentone 5
RxNorm normalized name: Thiopentone
DrugBank: Thiopental (DB00599)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thiopentone 5 mg kg‐1 and suxamethonium 1.5 mg kg‐1 (group TS)
Trial: 10434162
Drug: Alfentanil 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil 10 micrograms kg‐1 and propofol 3 mg kg‐1 (group PA)
Trial: 7598289
Drug: Spinal anesthesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal anesthesia (1.5 mL bupivacaine 0.75% with fentanyl 10 micrograms)
Trial: 2240678
Drug: High thoracic
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High thoracic segmental epidural anesthesia with bupivacaine (4.2 ml, 0.75%)
Trial: 773498
Drug: Labetalol 300
RxNorm normalized name: labetalol 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labetalol 300 mg daily
Trial: 773498
Drug: Labetalol 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labetalol 600 mg daily
Trial: 11764135
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (conventional treatment)
Trial: 1672049
Drug: esmolol 1
RxNorm normalized name: esmolol 10 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: esmolol 1 mg/kg and fentanyl 2 micrograms/kg
Trial: 6134622
Drug: Intravenous oxmetidine
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous oxmetidine (100 mg)
Trial: 6134622
Drug: Oral oxmetidine
RxNorm normalized name: cimetidine Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral oxmetidine (200 mg)
Trial: 24588905
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid (ZA) 5 mg, single intravenous infusion
Trial: 20213586
Drug: Gynostemma pentaphyllum
RxNorm normalized name: GYNOSTEMMA PENTAPHYLLUM TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gynostemma pentaphyllum tea (6 g daily for 12 weeks)
Trial: 16573847
Drug: Fluvoxamine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine (50 mg/d, increased by 50 mg weekly to a maximum of 150 or 300 mg/d)
Trial: 16342349
Drug: Levosimendan (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levosimendan (12 microg/kg loading dose for 15 minutes)
Trial: 12105237
Drug: Phosphate binders
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phosphate binders (including sevelamer hydrochloride, magnesium-based, iron-based, and lanthanum-based compounds)
Trial: 12105237
Drug: Aluminium gels
RxNorm normalized name: Aluminium
DrugBank: Aluminium phosphate (DB14517)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aluminium gels and calcium salts (historical context)
Trial: 7011819
Drug: SB 7505
RxNorm normalized name: SB 224289
DrugBank: SB 224289 (DB17052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB 7505 100 mg/day
Trial: 27031322
Drug: 500 cc
RxNorm normalized name: CC
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 cc dextrose 5% (group A)
Trial: 27031322
Drug: 500 cc
RxNorm normalized name: CC
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 cc normal saline (group B)
Trial: 21925828
Drug: T5: daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T5: daily heavy drinkers stopping early
Trial: 21925828
Drug: T3: nearly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T3: nearly daily heavy drinkers
Trial: 21925828
Drug: T4: daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T4: daily heavy drinkers
Trial: 19414713
Drug: Long-term treatment
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term treatment with sertraline hydrochloride
Trial: 19414713
Drug: Short-term treatment
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term treatment with sertraline hydrochloride
Trial: 19414713
Drug: Remission with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remission with treatment
Trial: 17786691
Drug: 6% maltodextrin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6% maltodextrin, 3% lemon juice solution (carbohydrate trial)
Trial: 15117902
Drug: Metformin (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (1000 mg bid for at least 16 weeks)
Trial: 9661120
Drug: Oral liquid
RxNorm normalized name: ACAI ORAL LIQUID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral liquid supplement containing arginine
Trial: 9661120
Drug: Oral liquid
RxNorm normalized name: ACAI ORAL LIQUID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral liquid supplement containing arginine plus omega-3 fatty acids
Trial: 2246697
Drug: Phenobarbital (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenobarbital (10 mg/kg)
Trial: 7437245
Drug: Erythromycin lactobionate
RxNorm normalized name: Erythromycin Lactobionate
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin lactobionate (single dose)
Trial: 7437245
Drug: Erythromycin lactobionate
RxNorm normalized name: Erythromycin Lactobionate
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin lactobionate (four doses)
Trial: 28319552
Drug: 5 mL
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mL of 0.5% mepivacaine (LC group)
Trial: 28319552
Drug: 5 mL
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mL of 1% mepivacaine (HC group)
Trial: 22095836
Drug: Multivitamin, mineral,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multivitamin, mineral, and herbal supplement for 8 weeks
Trial: 19266367
Drug: Celecoxib 400
RxNorm normalized name: celecoxib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 400 mg PO bid continuously until disease progression
Trial: 15041875
Drug: Prednisone (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (0.8 to 1.2 mg/kg for 3 days)
Trial: 11483325
Drug: HF‐ACC‐RCT with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HF‐ACC‐RCT with 2 cycles of 5‐FU (600 mg/m(2)/day)/carboplatinum (70 mg/m(2)) on days 1‐5 and 29‐33
Trial: 11483325
Drug: Prophylactically given
RxNorm normalized name: Caries prophylactic agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactically given G‐CSF (263 microg, days 15‐19)
Trial: 8056991
Drug: Clemastine 2
RxNorm normalized name: clemastine 2 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clemastine 2 mg (positive control)
Trial: 782307
Drug: C-1 group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C-1 group: 32 patients received one dose of i.t. methotrexate at the end of induction treatment and every three months.
Trial: 782307
Drug: C-2 group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C-2 group: 29 patients treated by cranial irradiation (2400 r.) and five doses of i.t. methotrexate after induction of remission.
Trial: 21359424
Drug: Botulinum neurotoxin
RxNorm normalized name: Botulinum neurotoxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum neurotoxin type-A (BoNT/A) administered as a 40 μl bolus, lateral to their nose, at 24 hours, 8, 15, 22, 29 or 36 days pre-formalin test (FT)
Trial: 21359424
Drug: Isotonic saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic saline solution 0.9% (control)
Trial: 20184444
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of paracetamol
Trial: 16772783
Drug: rhGH (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhGH (0.05 mg/kg body weight)
Trial: 14706580
Drug: Cimetidine hydrochloride
RxNorm normalized name: Cimetidine Hydrochloride
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine hydrochloride 1,200 mg daily (H(2)-blocker)
Trial: 14706580
Drug: Ranitidine hydrochloride
RxNorm normalized name: Ranitidine Hydrochloride
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine hydrochloride 200 mg daily (H(2)-blocker)
Trial: 14706580
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg twice daily for 5 days
Trial: 14706580
Drug: Neither H(2)-blocker
RxNorm normalized name: 2,2',3,3',4,4',5,5',6-nonachlorodiphenyl either
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neither H(2)-blocker nor omeprazole
Trial: 3546716
Drug: Metronidazole (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (1.5 g daily for 10 days)
Trial: 3546716
Drug: Tinidazole (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tinidazole (1.5 g daily for 10 days)
Trial: 3546716
Drug: Ornidazole (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ornidazole (1 g daily for 10 days)
Trial: 3546716
Drug: Metronidazole (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (0.5 g daily for 10 days)
Trial: 3546716
Drug: Tinidazole (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tinidazole (single 2 g dose)
Trial: 3546716
Drug: Ornidazole (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ornidazole (single 1 g dose)
Trial: 23521140
Drug: Articaine 40
RxNorm normalized name: articaine 40 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Articaine 40 mg (20 mg/ml)
Trial: 23842536
Drug: Oral ibuprofen
RxNorm normalized name: ibuprofen Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ibuprofen (10 mg/kg)
Trial: 17119689
Drug: Oral dipyrone
RxNorm normalized name: dipyrone
DrugBank: Metamizole (DB04817)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dipyrone (15 mg/kg)
Trial: 17119689
Drug: Intramuscular dipyrone
RxNorm normalized name: dipyrone
DrugBank: Metamizole (DB04817)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular dipyrone (15 mg/kg)
Trial: 17119689
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (oral ibuprofen, oral dipyrone, intramuscular dipyrone)
Trial: 17119689
Drug: Oral dipyrone
RxNorm normalized name: dipyrone
DrugBank: Metamizole (DB04817)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dipyrone
Trial: 11026949
Drug: New forms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New forms of psychological treatment for women newly diagnosed with early-stage breast cancer
Trial: 11026949
Drug: New forms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New forms of psychological treatment for families at risk of maladaptive bereavement
Trial: 8792361
Drug: Aspirin (650
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (650 mg, 1 capsule/day for 14 days)
Trial: 1284159
Drug: IS‐5‐MN 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IS‐5‐MN 20 mg three times daily
Trial: 1284159
Drug: Gallopamil 50
RxNorm normalized name: gallopamil 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gallopamil 50 mg three times daily
Trial: 1284159
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of IS‐5‐MN and gallopamil (same dosages as above)
Trial: 3969934
Drug: Weight lifting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight lifting exercise with RDA protein intake (0.8 g/(kg BW X d))
Trial: 30267294
Drug: Eluxadoline (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eluxadoline (75 mg or 100 mg)
Trial: 24652494
Drug: A/California/7/2009(H1N1)-AS03 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A/California/7/2009(H1N1)-AS03 vaccine (Ad2 group)
Trial: 24652494
Drug: Nonadjuvanted A/California/7/2009(H1N1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonadjuvanted A/California/7/2009(H1N1) vaccine (NAd2 group)
Trial: 24652494
Drug: A/California/7/2009(H1N1)-AS03 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A/California/7/2009(H1N1)-AS03 vaccine with saline placebo (control group)
Trial: 12722044
Drug: Fluvastatin, 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin, 40 mg/d (n = 13)
Trial: 10831023
Drug: Donepezil HCl
RxNorm normalized name: donepezil HCl
DrugBank: Donepezil (DB00843)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Donepezil HCl 5 mg for 4 weeks, followed by 10 mg for 8 weeks
Trial: 21555774
Drug: Self-administered teriparatide
RxNorm normalized name: Teriparatide
DrugBank: Teriparatide (DB06285)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Self-administered teriparatide
Trial: 15001624
Drug: Testosterone (Te)
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone (Te) 200 mg
Trial: 7961108
Drug: Paclitaxel 180
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 180 mg/m2
Trial: 7961108
Drug: Paclitaxel 75-180
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 75-180 mg/m2
Trial: 7961108
Drug: Paclitaxel (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel (various doses)
Trial: 27059990
Drug: Continuous-flow cryocompression
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous-flow cryocompression therapy
Trial: 18070947
Drug: Cell infusion
RxNorm normalized name: irrigation set MISCELL INFUSION SETS-PARAPHERNALIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cell infusion with PBSCs mobilised by G-CSF
Trial: 18070947
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no cell infusion)
Trial: 14656453
Drug: Oral yohimbine
RxNorm normalized name: YOHIMBINE
DrugBank: Yohimbine (DB01392)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral yohimbine (20 mg)
Trial: 14656453
Drug: Oral clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral clonidine (150 mg)
Trial: 11092167
Drug: Patient medication
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient medication counseling by a clinical pharmacist prior to discharge
Trial: 1489941
Drug: Lithium citrate
RxNorm normalized name: Lithium Citrate
DrugBank: Lithium succinate (DB14508)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lithium citrate syrup
Trial: 1489941
Drug: Lithium citrate
RxNorm normalized name: Lithium Citrate
DrugBank: Lithium succinate (DB14508)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lithium citrate syrup and Lithium carbonate tablets
Trial: 29249880
Drug: Implant-retained mandibular
RxNorm normalized name: betaine
DrugBank: Betaine (DB06756)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Implant-retained mandibular overdenture
Trial: 25498245
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (FO, 1.2 g/d n‐3 LCPUFA)
Trial: 19004197
Drug: Acupuncture plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture plus acupoint-injection
Trial: 19004197
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of carbamazepine (Control)
Trial: 12533551
Drug: Noncontact normothermic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noncontact normothermic wound therapy
Trial: 8592060
Drug: L-NAME (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NAME (25 nmol)
Trial: 8592060
Drug: L-NAME and
RxNorm normalized name: L-NAME
DrugBank: N-omega-nitro-L-arginine methyl ester (DB12750)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NAME and L-NMMA
Trial: 8592060
Drug: L-NAME (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NAME (12.5 or 25 pmol)
Trial: 20565458
Drug: Rupatadine 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rupatadine 10 mg + Lorazepam 2 mg
Trial: 15827094
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (all doses)
Trial: 12072596
Drug: Interferon alpha‐2b
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alpha‐2b (3 MU three times weekly) for 52 weeks in combination with ribavirin
Trial: 12072596
Drug: Interferon alpha‐2b
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alpha‐2b (3 MU three times weekly) for 52 weeks without ribavirin (placebo)
Trial: 3622594
Drug: Diltiazem 60
RxNorm normalized name: DILTIAZEM 60MG 12HR CAP,SA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 60 mg thrice daily